Skip to main content

Applied Cancer Therapeutics and Outcomes

Applied Cancer Therapeutics and Outcomes

We develop, deliver and test novel clinical therapeutics relevant to cancer.
 
Our goal is to reduce cancer incidence, morbidity and mortality.

Research scope

Our research covers:

  • prevention
  • clinical response to treatment 
  • toxicity and treatment side effects
  • survival and other clinical outcomes
  • survivorship

Research activity

Our research activity spans the entire patient and cancer therapeutic journey from primary prevention to end of life.

The theme’s definition of therapeutics is broad and includes:

  • interventions for primary prevention
  • screening modalities
  • preclinical biomarkers
  • diagnostic tools
  • cancer treatments
  • survivorship and end-of-life interventions

Research focus

Areas of our research focus include:

  • optimal prevention and early diagnosis strategies
  • identification of mechanistic predictive and prognostic biomarkers to stratify for patient benefit or toxicity
  • genomics and clinical pharmacokinetics and therapeutic drug monitoring in optimising drug dosing
  • the design, development and delivery of biologically-rich clinical trials with translational sample collection
  • studies of survivorship and patient outcomes following treatment
  • development and testing of a wider range of interventions and services to improve survivorship care and patient outcomes